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It is not present in mammals so may be exploited as an antimicrobial drug target or used as a substitute 
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Here, we use steady-state and pre-steady-state kinetics combined with mutagenesis and structural 
Ǧ ?Caldalkalibacillus thermarum. We show that the 
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partner site. We conclude that the reaction pathway is determined stochastically, by the substrate/
product concentrations and dissociation constants, and can follow either a ping-pong or ternary 
Ǥ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foundation for the development of therapeutic strategies.
Type-II NADH:quinone oxidoreductase (NADH dehydrogenase-2, NDH-2) is a membrane-bound dehydroge-
nase that oxidizes NADH and reduces quinones and is a central feature of the respiratory chain in many diverse 
species, but not in animals1. Unlike in NDH-1 (respiratory complex I, which catalyzes the same reaction in ani-
mals and many other species) catalysis by NDH-2 is not used to support the proton motive force that drives ATP 
synthesis, so its catalysis is highly exergonic and essentially irreversible. NDH-2 is also much smaller and simpler 
in structure than complex I – it comprises only a single subunit and one lavin redox cofactor1,2. Consequently, 
it has been explored as a gene therapy for human complex I disorders, to relieve the accumulation of NADH and 
decrease reactive oxygen species (ROS) production3–6. In notable pathogenic microorganisms NDH-2 is essential 
for growth, even in some organisms that contain both complex I and NDH-2 such as Mycobacterium tuberculosis7. 
Together with the presence of NDH-1 in mammalian species, this has rendered NDH-2 an attractive drug 
target8–11.
Three NDH-2 homologues have been characterized structurally, from Saccharomyces cerevisiae12,13, 
Caldalkalibacillus thermarum14, and Staphylococcus aureus15. All of them are homodimers, with each monomer 
containing two Rossmann folds that form nucleotide-binding sites for a noncovalently bound lavin adenine 
dinucleotide (FAD) and the NADH substrate. For the S. cerevisiae enzyme (known as Ndi1), the two publications 
on the structure described contradictory substrate-binding sites. Iwata et al. generated co-crystals of Ndi1 with 
either NAD+ or ubiquinone-2 bound (but not both) and found their binding sites to be coincident12, precluding 
formation of a ternary complex (in which both substrates are bound together). Alternatively, Feng et al. applied 
NADH and ubiquinone-4 to NDH-2 crystals together and observed separate densities for the nucleotide and the 
quinone, so they concluded the binding sites are distinct, allowing formation of a ternary complex13. In fact, Feng 
et al. observed two quinone-binding sites (one in both NDH-2:ubiquinone-4 and NADH:NDH-2:ubiquinone-4 
co-crystals, the other only in the absence of nucleotide), but the second site is probably an artifact of the high 
(0.5 mM) ubiquinone-4 concentration used.
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he catalytic mechanism of NDH-2 is currently unclear. Kinetic analyses of the S. cerevisiae, Yarrowia lipo-
lytica, Toxoplasma gondii and M. tuberculosis enzymes using Hanes-Woolf, Lineweaver-Burk and Cook-Cleland 
reciprocal plots9,16–20 concluded that they follow a ping-pong mechanism in which the substrates bind, react and 
dissociate sequentially, either in the same binding site (a one site ping-pong mechanism) or in discrete binding 
sites (a two site ping-pong mechanism). In a ping-pong mechanism, the two substrates are never bound together 
(Fig. 1A). Alternatively, others have observed charge transfer complexes (CTCs, complexes in an intermediate 
state between NADH/oxidized lavin and NAD+/reduced lavin)15,21 and suggested that the CTC is the species 
oxidized by quinone15 in a step in which both substrates are bound to the enzyme at the same time. In a classical 
ternary complex mechanism, both substrates are bound together and both products released simultaneously 
(Fig. 1B), whereas in NDH-2 formation of a stable CTC suggests that NADH oxidation has already occurred to 
some extent, before the quinone reacts. Consequently, the ternary complex proposed to be formed during NDH-2 
catalysis is atypical because the ternary complex has the character of a substrate-product complex (Fig. 1C). he 
structures of Feng et al.13 demonstrated that ternary complex formation is possible, but do not deine the mecha-
nism because the observed ternary complex may not be necessary, or even catalytically relevant.
Here, we present a comprehensive analysis of the catalytic mechanism of NDH-2 from C. thermarum using 
kinetic, spectroscopic and structural methods on both the wild-type (WT) enzyme and on site-directed mutants 
in which the substrate-binding sites have been individually ablated. We ind that the two substrate reactions are 
independent of one another, and that the pathway followed is determined by the relationships between the sub-
strate and product concentrations and enzyme dissociation constants. his mechanistic versatility provides a uni-
ied explanation for all extant data, and, by characterizing the speciic states and substrate-binding sites required 
for catalysis, provides a foundation for the future design and evaluation of candidate inhibitors.
Results and Discussion
Ǧ ?ƤǦǤ Figure 2 (let) shows a set 
of spectra for NDH-2 in diferent redox and nucleotide-binding states. Panel A shows that addition of NADH to 
the oxidized enzyme both reduces the lavin (most evident at 350 to 500 nm) and forms a charge-transfer com-
plex (CTC, evident above 550 nm with a maximum at 660 nm)15,21. Because the reduction potential of the lavin 
(ca. − 0.22 V15) is considerably higher than that of NADH (− 0.32 V) the CTC is probably best described as NAD+ 
bound to reduced lavin. he CTC is stable, suggesting that NAD+ does not dissociate from the reduced lavin 
following hydride transfer, and panel B shows the CTC is also formed by addition of NAD+ to the pre-reduced 
lavin. herefore, our data suggest that NAD+ remains bound following the redox reaction simply because it is 
tightly bound, not because it is ‘trapped’ by a conformational change controlled by the lavin’s redox state.
In principle, it is possible to measure the dissociation constant for NAD+ by combining these titration data 
with the tight-binding equation, but the values obtained are inaccurate because the enzyme:substrate complex 
is always present at close to stoichiometric level. However, the data provide an upper limit for KD of 2 µ M — 
considerably lower than the values of 11.4 and 20.3 µ M determined for S. aureus NDH-2 by titrating NADH 
and NAD+ onto the protein and monitoring the luorescence from two nearby tryptophans15. Our attempts to 
replicate the same experiments here were unsuccessful due to absorption by the nucleotides at the frequencies 
used for excitation and/or emission (the inner ilter efect). For S. aureus NDH-2, the tryptophan residues were 
excited at 280 nm, and their emission measured at 330 nm. Here, the absorption of both NAD+ (which has an 
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Figure 1. Reaction mechanisms relevant to NDH-2 catalysis. he binding sites for NADH/NAD+ and Q/QH2 
are shown shaded in red and blue, respectively. (A) Ping-pong mechanism in which NADH and Q (quinone) 
react sequentially and are never bound to the enzyme at the same time. (B) Classical ternary mechanism in 
which both substrates bind to form a ternary complex, the reaction occurs, and both products dissociate. (C) 
Atypical ternary mechanism that better relects proposed mechanisms for NDH-2, in which NADH binds and 
reacts but NAD+ does not dissociate, then Q binds and reacts in a ternary complex with the enzyme-product 
complex.
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absorption maximum at 260 nm that extends to 280 nm) and NADH (maximum absorption at 340 nm) precluded 
identiication of any changes due to nucleotide binding. Signiicant luorescence changes were not observed from 
the lavin in either S. aureus, C. thermarum, or Escherichia coli NDH-222, monitored at 450 and 530 nm (at which 
wavelengths the nucleotides do not absorb).
Figures 2A and B (right) further show that the (approximately stoichiometric) NADH + oxidized lavin and 
NAD+ + reduced lavin reactions that generate the CTC are fast and essentially complete within 50 ms (in 2 µ M 
NADH the lavin is reduced at ~200 s−1). In contrast, Fig. 2C shows that addition of NADPH reduces the la-
vin – but no CTC is observed unless a very large excess of NADP+ is added to the reduced enzyme, and even 
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Figure 2. Spectra of NDH-2 in diferent redox and nucleotide-bound states. (A) Let, the spectrum of ~70 µ M 
oxidized NDH-2 is in black (Ox), then subsequent spectra show how the spectrum evolves upon addition 
of 10 µ M aliquots of NADH. Wavelengths below 500 nm show lavin reduction, wavelengths above 500 nm 
formation of the charge-transfer complex (CTC). he inset shows the CTC absorbance plotted against NADH 
concentration showing the CTC is formed close to stoichiometrically with NADH. he asterisks mark two 
signals from a low-level but strongly absorbing contaminant heme protein (which is estimated to be present 
at less than 2% of the concentration of NDH-2). Right, diference spectra (spectrum at the reported timepoint 
minus the oxidized spectrum) for the reaction of 4 µ M oxidized NDH-2 with 5 µ M NADH (concentrations 
ater mixing) showing rapid lavin reduction and CTC formation. (B) Let, the spectrum of ~70 µ M oxidized 
NDH-2 is in black (Ox) and that of the dithionite-reduced enzyme in violet (marked Red). Subsequent spectra 
follow the addition of aliquots of NAD+ to generate a inal spectrum equivalent to in A. Right, diference 
spectra (relative to the 1 ms spectrum) for the reaction of 4 µ M dithionite-reduced NDH-2 with 4.5 µ M NAD+ 
(concentrations ater mixing). (C) An experiment equivalent to in (A) but with NADPH instead of NADH. Let, 
NADPH reduces the lavin but does not form the CTC; when an extremely high concentration of NADP+ is 
added a very weak CTC signal can be observed (for the 6.25 mM spectrum shown the 80 µ M spectrum has been 
subtracted and the diference spectrum expanded by 5). Right, reduction of 4 µ M NDH-2 by 5 µ M NADPH 
(diference spectra relative to the 1 ms spectrum, concentrations ater mixing) is much slower than reduction by 
NADH.
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then it is only present at low level. Furthermore, the NADPH + oxidized lavin reaction requires more than 10 s, 
so it is three orders of magnitude slower than the NADH reaction (in 2 µ M NADPH the lavin is reduced at 
~0.3 s−1). Steady-state rates for the NADPH:menadione and NADH:menadione oxidoreduction reactions sup-
port this comparison (in 30 µ M NAD(P)H and 400 µ M menadione the rates were ~1 and ~880 s−1, for NADPH 
and NADH respectively). Together, these observations indicate that the ainity of NDH-2 for NADP+/NADPH 
is much lower than for NAD+/NADH. he low NADP+/NADPH ainity can be explained by the structure of 
NDH-2 with NAD+/NADH bound (discussed later), by unfavorable interactions between the side chain of E198 
and the adenine nucleotide phosphate. Indeed, sequence analyses suggests that the majority of NDH-2 variants 
contain Glu or Asp at this position and so react only with NADH2, and the corresponding Glu to Gln mutation in 
Agrobacterium tumefaciens NDH-2 was demonstrated to change its speciicity towards NADPH23.
Flavin oxidation by quinone does not depend on nucleotide binding. Figure 3 shows kinetic traces 
for oxidation of the reduced lavin by menadione, a short-chain analogue of the physiological menaquinone, 
either with the nucleotide-binding site occupied by NAD+ (Fig. 3A), or unoccupied (Fig. 3B). he NAD+-bound 
enzyme was generated by reduction with a sub-stoichiometric concentration of NADH, and the nucleotide-free 
enzyme with NADPH. For the NAD+-bound enzyme, reoxidation of the lavin by a sub-stoichiometric con-
centration of menadione is mirrored by loss of the CTC (for the nucleotide-free enzyme the CTC is absent). 
Importantly, the rate of lavin reoxidation by menadione is essentially identical in both cases (~200 s−1 in 1.5 µ M 
menadione), showing that quinone reduction does not depend on the nucleotide-binding site occupancy. 
Furthermore, the rates of lavin reduction by NADH (Fig. 2) and lavin reoxidation by menadione (Fig. 3) are 
comparable. hese observations demonstrate that NDH-2 catalysis can follow either a ternary-complex mech-
anism (as with NADH) or a ping-pong mechanism (as with NADPH, Fig. 1A), with the route taken deter-
mined simply by the ainity of the oxidized nucleotide for the reduced lavin (and its rate of dissociation). For 
NADH:menadione oxidoreduction, oxidation of the nucleotide-bound lavin by menadione causes rapid nucle-
otide dissociation from the oxidized lavin, implying that the NAD+ dissociation constant is strongly dependent 
on lavin oxidation state. Finally, due to the formation of the stable CTC between NAD+ and the reduced enzyme, 
the quinone most likely reacts with the NAD+: reduced lavin complex, which is an enzyme-product complex. 
here is no suggestion that both substrates must bind before reacting together in a common transition state, and 
so the NADH:menadione oxidoreduction reaction follows an atypical ternary mechanism (Fig. 1C), rather than 
a classical ternary mechanism (Fig. 1B).
ǦǦǦ ?Ǥ he structure of C. thermarum 
NDH-2 has been described, but attempts to determine the structures of its substrate-bound states were previ-
ously unsuccessful14. Here, we have determined structures of NDH-2 co-crystallized with either 1 mM NADH 
or 10 mM NAD+ to 2.5 and 3.0 Å resolution, respectively. he two nucleotide-bound structures are very similar, 
so we describe the structure with NADH, which likely represents NAD+ bound to the reduced lavin as the 
product of NADH oxidation. NAD(H) did not alter the crystal packing or unit cell parameters signiicantly (see 
Supplementary Table 1) and the RMSD, between the nucleotide-bound and -free structures, was 0.52 Å over 
394 Cα atoms. No structure has been determined for C. thermarum NDH-2 with a quinone bound, but the high 
similarity of NDH-2 and Ndi1 readily allowed the bound quinone observed in Ndi113 to be modeled into NDH-2 
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Figure 3. Re-oxidation of the reduced lavin in NDH-2 by menadione in the presence and absence of 
bound nucleotide. A solution of 8 µ M NDH-2 was sub-stoichiometrically pre-reduced by addition of NADH 
(A) or NADPH (B) to generate 4 µ M reduced enzyme (determined spectroscopically), then loaded into the 
stopped-low apparatus. It was reacted at a concentration of 2 µ M reduced enzyme with 1.5 µ M menadione 
(concentrations following mixing) with the sub-stoichiometric ratios used to ensure all the reactants are 
consumed. he data points are average values from three technical replicates with error bars ± SEM (n = 3). 
he absorbance from the lavin (red, average absorbance from 438 to 464 nm) increases upon oxidation. he 
absorbance from the CTC (blue, average absorbance from 639 to 684 nm), only evident in the NADH-reduced 
protein, is lost upon oxidation. Each trace is shown itted with a irst-order rate constant of 200 s−1; the best-it 
values are 170 (lavin) and 130 (CTC) s−1 in A and 220 s−1 in (B).
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on the opposite face of the lavin to the nucleotide-binding site (the second, distant site observed in Ndi1 is 
blocked in NDH-2 by the irst amphipathic helix of the membrane-anchoring domain)14. Figure 4A shows an 
overview of the structure of C. thermarum NDH-2, showing the FAD and both substrates bound. Clear density 
for the bound nucleotide was observed in the NADH-NDH-2 structure, with the nicotinamide ring juxtaposed 
over the lavin in a position consistent with hydride transfer, equivalent to that observed in Ndi113,24 (see Fig. 4B 
and Supplementary Fig. 1). Interestingly, although few changes can be identiied between the nucleotide-bound 
and nucleotide-free structures, the side chain of Phe165 moves away from the re-face of the FAD upon nucleotide 
binding, as a conserved feature of FAD-dependent reductases that use NADH or NADPH25, and the side chain 
of Phe207 shits to avoid Phe165. he close similarity of the two structures is consistent with our proposal that 
NAD+ is retained at the reduced lavin simply because of its high ainity, not because of a conformational ‘switch’ 
that must open to allow it to dissociate.
Mutations that target the NADH- and quinone-binding sites. To test the proposal that the two sub-
strate reactions are independent of each other we mutated a key residue in each substrate-binding site. G164 is 
positioned next to the adenine-proximal ribose of the bound nucleotide and I379 is positioned at the entry to 
the quinone-binding pocket. Structures of the two mutants (Fig. 4C,D), at 3.2 and 2.7 Å resolution, respectively 
(Supplementary Table 1), conirmed that the structural changes are localized and the integrities of the structures 
are maintained. G164E crystallized in a diferent space group (P41212) to the wild-type (WT) protein, but the 
glutamate side chain could be observed conidently in only one of two molecules in the asymmetric unit. On the 
other hand, I379E crystallized in the same space group as the WT and the side chain was observed in three of four 
molecules in the asymmetric unit. In comparison with WT, G164E and I379E exhibit RMSD values of 0.54 Å (Cα 
of 395 residues) and 0.45 Å (Cα of 393 residues), respectively, with no substantial additional diferences.

 ? ? ? ? ? ?Ƥ
are independent of each other. Figure 5 shows steady-state kinetic data on WT NDH-2 and its G164E 
and I379E variants. For WT, the KM values are 29 µ M for NADH and 34 µ M for menadione. For the G164E variant 
the KM for NADH increases drastically to more than 1 mM, consistent with the mutation compromising NADH 
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Figure 4. Structures of NDH-2 substrate-binding sites and variants. (A) Overview of the structure of NDH-2 
showing the location of the membrane interface, the FAD (blue) and two bound substrates (yellow/orange). he 
structure is for NDH-2 co-crystallized with 1 mM NADH; menadione was modeled into its site as described 
previously14. (B) he structures of NDH-2 crystallized in the presence (white) and absence (wheat) of NADH 
are overlaid. he nicotinamide ring of the nucleotide (yellow) is juxtaposed on the FAD (blue) isoalloxazine 
ring system at a distance of 3.2 Å (C4′ of the nicotinamide ring to N5 of the FAD). he carboxyl side chain of 
conserved E198 forms two hydrogen bonds to the adenine ribose and the side chain of F165 changes position 
(green to cyan) upon nucleotide binding. (C) he structures of wild-type NDH-2 (wheat) and the G164E 
variant (white) are overlaid. NADH has been added for reference only and it clashes with the side chain of E164. 
(D) he structures of wild-type NDH-2 (wheat) and the I379E variant (white) are overlaid. Menadione has been 
added for reference only and it clashes with the side chain of E379.
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binding. Furthermore, the observed rates drop drastically (only ~1% of the WT activity is observed in even 600 µ M 
NADH), and, as a consequence, the apparent KM value for menadione decreases signiicantly because the turn-
over rate is ‘capped’ by the slow rate of NADH oxidation. For the I379E variant, the KM for menadione increases 
signiicantly, to 780 µ M, consistent with the mutation compromising quinone binding. Again, the observed rates 
are lower, with the maximal rate equivalent to ~60% of the WT rate, and, as expected, the apparent KM value for 
NADH has decreased.
Figure 6A shows that NADH is able to reduce the oxidized G164E variant, but it does not form a CTC. 
Subsequent additions of NAD+ to the reduced protein also failed to produce a CTC. Figure 6C shows that the 
reaction between G164E and NADH is very slow (~0.2 s−1 in 2 µ M NADH), similar to the reaction of the WT with 
NADPH (~0.3 s−1 in 2 µ M NADPH), consistent with weak nucleotide binding. Conversely, when NADH-reduced 
G164E was reacted with menadione (Fig. 6E) rapid oxidation of the lavin (~175 s−1 in 1.5 µ M menadione, match-
ing the ~200 s−1 rate for WT) was observed, demonstrating that the quinone-binding site is fully functional, 
irrespective of the functionality of the NADH-binding site. I379E displays the opposite behavior. When oxidized 
I379E reacts with NADH, the lavin is reduced and a CTC forms, as in the WT enzyme (Fig. 6B). As in the WT 
enzyme the reaction with NADH is rapid (Fig. 6D, ~290 s−1 in 2 µ M NADH), but when the NADH-reduced 
enzyme is exposed to menadione the reaction is very slow (Fig. 6F, ~3 s−1 in 1.5 µ M menadione). herefore, 
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Figure 5. Steady-state kinetic data comparing the wild-type enzyme and NDH-2 variants. Measurements 
made with varying NADH concentrations used 400 µ M menadione, and measurements with varying 
menadione concentrations used 100 µ M NADH. he data were it to the Michealis-Menten equation. he data 
points are average values from three technical replicates with error bars ± SEM (n = 3).
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in the I379E variant the menadione reaction is compromised but, irrespective of the functionality of the 
quinone-binding site, the NADH-binding site functions properly. Our results demonstrate that the decreased 
steady-state rates observed in Fig. 5 do indeed stem from speciic ablation of one of the two active sites, and con-
irm that the two sites function independently.
Production of reactive oxygen species. It has been suggested that the tight interaction between nucle-
otides and the lavin represented by the CTC has evolved to minimize ROS production by the reduced lavin15,21. 
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Figure 6. Reactions of the G164E and I379E variants with NADH and menadione. (A and B) spectra of 
the oxidized and NADH-reduced G164E and I379E variants. he heme-containing contaminant (marked by 
asterisks) is clearly visible in I379E (but estimated to be present at less than 2% of the concentration of NDH-2). 
(C and D) reactions of oxidized G164E (3.4 µ M) and I379E (4 µ M) with 2 µ M NADH (concentrations following 
mixing). (E and F) Solutions of 6.8 µ M G164E and 8 µ M I379E were sub-stoichiometrically pre-reduced by 
addition of NADH to generate 3.6 µ M reduced G164E and 6 µ M reduced I379E (determined spectroscopically), 
then loaded into the stopped-low apparatus. hey were reacted at concentrations of 1.8 µ M reduced G164E and 
3 µ M reduced I379E with 1.5 µ M menadione (concentrations following mixing) with the sub-stoichiometric 
ratios used to ensure all the reactants are consumed. In (C–F) the data points are average values from 
three technical replicates with error bars ± SEM (n = 3), reported in absorbance units per µ M enzyme. he 
absorbance traces are from the lavin (red, average absorbance from 438 to 464 nm, decreases upon reduction) 
and from the CTC (blue, average absorbance from 639 to 684 nm). G164E does not form a CTC (A) and reacts 
very slowly with NADH (not visible on the experimental timescale, C) whereas I379E reacts rapidly with 
NADH to form a CTC (B and D). NADH-reduced G164E is oxidized rapidly by menadione (E) whereas I379E 
reacts much more slowly (F).
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herefore, rates of H2O2 production were measured in air by monitoring the reduction of Amplex Red to resoruin 
by horse-radish peroxidase, and conirmed by monitoring NAD(P)H oxidation26. he rate of NADH-driven H2O2 
production (0.11 ± 0.01 (n = 4) µ mol H2O2 min−1 mg−1 or ~0.085 s−1) is slower than the NADPH-driven rate 
(~0.185 s−1) measured under the same conditions. Consistent with a small efect of the CTC in minimizing ROS 
production, little diference in NADH-driven ROS production was observed between the WT and I379E variant 
(~0.085 vs. ~0.088 s−1), whereas the rate of NADH-driven ROS production by G164E matches the WT-rate with 
NADPH (~0.167 vs. ~0.185 s−1). However, all of these rates are very low in comparison to the rates of catalysis 
observed with NADH and menadione, questioning whether they are suicient to drive the evolution of the CTC.
Evaluation of kinetic data that indicated a ping-pong mechanism for NADH: quinone oxidore-
duction. First, NDH-2 was demonstrated to catalyze the transhydrogenation reaction between NADH and 
thioNAD+, an NAD+ analogue in which the amide on the nicotinamide ring is replaced with a sulfonamide. 
Because both NAD(H) and thioNAD(H) must occupy the nucleotide-binding site to exchange a hydride with 
the lavin, the transhydrogenation reaction was taken as evidence for ping-pong kinetics20. Here, we tested the 
NADH:APAD+ reaction, in which APAD+ is an NAD+ analogue with the amide replaced by an acetyl group 
and a higher potential (− 240 mV at pH 7) than that of NADH (− 340 mV)27. Michaelis-Menten analyses for the 
NADH:APAD+ reaction showed that Vmax is 2.9 µ mol NADH min−1 mg protein−1 (~500 times slower than for the 
NADH:menadione reaction), and KMAPAD+ is 7.2 µ M. Subsequently, titrating APAD+ onto the reduced enzyme 
showed that, like NAD+, it binds tightly to form a CTC, although due to the higher potential of APAD+ slow la-
vin oxidation is evident. During transhydrogenation, APAD+ must compete with NAD+ for the reduced lavin, 
so the reaction is very slow because NAD+ dissociation is very slow. he rate of the NADH:thioNAD+ reaction 
was similarly observed to be ~2000 times slower than the NADH:Q reaction20. hus, the slow transhydrogenation 
reaction does occur by a ping-pong mechanism, but this does not dictate that the much faster NADH:menadione 
reaction must do so also. Indeed, menadione reacts at a diferent site, avoiding the need to ‘wait’ for NAD+ 
dissociation.
Second, the Cook-Cleland analysis and standard double-reciprocal kinetic analyses were used previously to 
support proposals for the ping-pong mechanism. Yano and coworkers used Cook-Cleland analyses, in which 
data are taken at a constant ratio between the two substrates and plotted in double-reciprocal form. he plots 
are expected to be linear if the reaction follows a ping-pong mechanism, or curved for a ternary mechanism28 
and the plot for NDH-2 was linear9. Two standard forms of double-reciprocal plot analyses have also been used. 
Parallel lines in Lineweaver-Burk plots, as observed for NDH-2 catalysis9,16,18, are a typical feature of ping-pong 
reactions28, and the same data can also represented by a Hanes-Woolf plot9,17–19. However, as noted by Cook and 
Cleland28, these analyses only show that the data are compatible with ping-pong kinetics: similar plots can also 
be produced by reactions with diferent mechanisms. Figure 7A shows a simple ternary-reaction scheme for 
NDH-2 catalysis which considers that either NADH or menadione may bind irst. Using this scheme the data 
in Fig. 7B–D were calculated using parameters that reproduce the WT data in Fig. 5: the parameters used are 
plausible, but many other combinations are also capable of itting the data in Fig. 5 and more extensive studies 
would be required to determine their values properly. Figure 7B shows that the ternary mechanism scheme gives 
rise to a linear Cook-Cleland plot, Fig. 7C shows that it gives parallel lines in a Lineweaver-Burk plot, and Fig. 7D 
shows the corresponding Hanes-Woolf plot with all the lines intersecting on the y-axis (matching kinetic data 
presented previously9,17–19). herefore, kinetic analyses using these methods are incapable of distinguishing the 
reaction mechanism for NDH-2 catalysis, and previous conclusions of ping-pong kinetics based on these analyses 
cannot be relied upon.
Ǧ ?Ǥ he mechanism of NDH-2 is variable: the reaction fol-
lows diferent pathways through the network of possible states depending on the concentrations of reactants and 
products present, and their diferent binding constants. During enzyme turnover with NADH and menadione the 
reaction predominantly follows a ternary-type mechanism in which, following NADH oxidation, NAD+ binds 
tightly to the reduced lavin (forming a CTC) and only dissociates when the lavin is oxidized by menadione 
(Fig. 1C). In this mechanism, menadione reduction occurs within a ternary product complex. Conversely, during 
slow enzyme turnover with NADPH and menadione the reaction most likely displays ping-pong kinetics: NADP+ 
does not bind tightly to the reduced lavin so it dissociates rapidly and thus menadione is more likely to react with 
the nucleotide-free reduced lavin (Fig. 1A). However, the ping-pong mechanism is not enforced, it simply results 
from the relative rates of the diferent microscopic reaction steps. Furthermore, our data are consistent with com-
parable rates for NADH oxidation and menadione reduction, so the identity of the rate-limiting step depends 
strongly on the relative concentrations of the two substrates. Finally, the NADH- and menaquinone-binding sites 
operate completely independently of one another, so in all cases the pathway followed for each individual turno-
ver of each independent enzyme molecule is determined stochastically.
Implications for the development of therapeutic strategies. Our study has revealed how the 
NADH:quinone oxidoreduction reaction proceeds in two half reactions (NADH oxidation + reduction of the 
lavin, and re-oxidation of the lavin + reduction of quinone) that occur independently of each other and use 
spatially distinct substrate-binding sites. hus, NDH-2 possesses two targetable sites for the development of com-
petitive inhibitors. Furthermore, our new mechanistic information provides a molecular framework by which 
to understand and validate the modes of action of candidate inhibitors that may relate to either inhibition of 
NADH or quinone binding. Many compounds, including phenothiazines, quinolinyl pyrimidines, quinolones, 
nanaomycin A and polymyxin B have been identiied as inhibitors of NDH-2 from pathogenic microorgan-
isms8,9,19,29–32, but their modes of action remain unclear. Furthermore, these compounds are not speciic to NDH-
2, and of-target side-efects have been reported33. Deining the catalytic mechanism of NDH-2 is a critical step in 
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establishing a platform for inhibitor validation and may assist in the further application of medicinal chemistry to 
improve the potency and speciicity of candidate inhibitor classes.
Methods
ǦƤǤ he modiied QuickChange 
method of Liu and Naismith34 was adapted to construct the G164E and I379E expression plasmids with pTRC-
ndh214 as a template. E. coli C41 (DE3)35 cells were transformed with each plasmid, and enzyme expression and 
puriication conducted as described previously14. Protein concentrations were measured using the Pierce™ BCA 
protein assay kit.
Kinetic and spectroscopic analyses. All kinetic analyses were performed in 50 mM Tris-Cl, 150 mM 
NaCl, 1% octylglucoside (OG), pH 8.0. he OG provides a hydrophobic volume to accommodate the menadi-
one substrate and maintains the enzyme in an active state. Steady-state kinetic measurements were at 37 °C in a 
96-well SpectraMax plate reader and monitored by the absorbance of NADH (340–380 nm, ε = 4.81 mM−1 cm−1) 
or APADH (400–450 nm, ε = 3.16 mM−1 cm−1). Enzyme concentrations used were typically 8 ng mL−1 for the 
wild-type reacting with NADH, but were increased up to 1 µ g mL−1 for variants/reactions with lower turnover 
rates. Pre-steady-state measurements were at 23 °C in an SX20 stopped low spectrometer (Applied Photophysics, 
dead time ~1 ms) itted with a photodiode array detector and housed in an anaerobic glovebox. he lavin oxida-
tion state was monitored by the average absorbance over 438 to 464 nm, and the CTC by the average over 639 to 
684 nm (taking average values over these wavelength ranges improved the signal:noise ratio). When required, the 
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Figure 7. Double-reciprocal analyses for a proposed ternary mechanism. (A) A possible ternary 
mechanism scheme for NDH-2 that includes two branches, depending on whether menadione (MD) or 
NADH binds irst. he constants k1 and k−1 for NADH binding, k2 and k−2 for Q binding and kN and kMD 
for their respective reactions do not depend on the sequence of events. Fox and Fred refer to the oxidized and 
reduced states of the FAD, respectively. (B–D) Data calculated using the scheme in panel A and a plausible set 
of parameters determined by trial and error to match the data in Fig. 5: k1 = 1.7 × 108 M−1 s−1; k−1 = 5000 s−1; 
k2 = 1.1 × 108 M−1 s−1; k−2 = 5000 s−1; kN = 3000 s−1 and kMD = 3000 s−1. (B) Cook-Cleland plot with the 
menadione concentration in a constant ratio of 6:1 with the NADH concentration. (C) Lineweaver-Burk plot 
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lavin was pre-reduced using small aliquots of sodium dithionite, NADH or NADPH, then the concentration of 
reduced enzyme conirmed spectroscopically in control stopped-low experiments against bufer-only solutions.
Crystallography. NDH-2 variants were crystallized by hanging-drop vapor difusion at 18 °C using drops 
containing 0.5 µ L of 30 mg mL−1 protein + 1 µ L of mother liquor set against 1 mL reservoir solutions. 0.5 µ L of 
seeding stock, prepared using Hampton seeding tubes (100 µ L of 0.1 M Bicine/Tris bufer pH 8.5, 10% (w/v) 
PEG 4000, 25% (v/v) ethylene glycol) were added to each drop to promote crystallization. Typically, small crys-
tals appeared overnight and were harvested on day four. G164E crystallized best in 0.1 M Bicine/Tris bufer 
(pH 8.5) containing 10% (w/v) PEG 4000, 25% (v/v) ethylene glycol and 30 mM D, L-lysine, and I379E in 
55 mM D, L-lysine. he wild-type protein was crystallized with 10 mM NAD+ or 1 mM NADH (WT-NAD+ 
and WT-NADH) using the same bufer but without D, L-lysine. Crystals were lash-frozen and stored in liquid 
nitrogen. Difraction data were collected at the Australian Synchrotron MX2 beam-line equipped with an ADSC 
Quantum 315r detector. G164E data were collected using a 20 µ m micro-collimator with 0% beam attenuation, 5 s 
exposures and 1° oscillation angle, and I379E and WT-NAD+ data with 30% beam attenuation and 1 s exposures. 
Five WT-NADH datasets were collected from three crystals with varying attenuation (0–30%) and exposure 
times (1–2 s) and from a further small crystal using the micro-collimator. Data were processed using XDS36. 
130° of data from G164E were merged and scaled using Aimless in the CCP4 suite37, and similarly 140° for I379E 
and 160° for WT-NAD+. For WT-NADH, 130°, 49°, 160°, 70° and 40° of each dataset were merged. Molecular 
replacement was performed using Phaser38 with a polyalanine WT model (PDB:4NWZ). he structures were 
reined using PHENIX39 with NCS restraints applied, COOT40 was used for model building and PyMOL to create 
the igures. Co-ordinates and structure factors have been deposited in the Protein Data Bank with Accession 
Numbers 5KMP, 5KMQ, 5KMR and 5KMS.
References
1. Melo, A. M. P., Bandeiras, T. M. & Teixeira, M. New Insights into Type II NAD(P)H: quinone oxidoreductases. Microbiol. Mol. Biol. 
Rev. 68, 603–616 (2004).
2. Marreiros, B. C., Sena, F. V., Sousa, F. M., Batista, A. P. & Pereira, M. M. Type II NADH:quinone oxidoreductase family: phylogenetic 
distribution, structural diversity and evolutionary divergences. Environ. Microbiol (2016) in press.
3. Bai, Y. et al. Lack of complex I activity in human cells carrying a mutation in mtDNA-encoded ND4 subunit is corrected by the 
Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) Gene. J. Biol. Chem. 276, 38808–38813 (2001).
4. Seo, B. B. et al. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of 
Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deicient mammalian cells. Proc. Natl. 
Acad. Sci. USA 95, 9167–9171 (1998).
5. Seo, B. B., Marella, M., Yagi, T. & Matsuno-Yagi, A. he single subunit NADH dehydrogenase reduces generation of reactive oxygen 
species from complex I. FEBS Lett. 580, 6105–6108 (2006).
6. Sanz, A. et al. Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary 
restriction. Proc. Natl. Acad. Sci. USA 107, 9105–9110 (2010).
7. Griin, J. E. et al. High-resolution phenotypic proiling deines genes essential for mycobacterial growth and cholesterol catabolism. 
PLoS Pathog. 7, 1–9 (2011).
8. Weinstein, E. a. et al. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc. Natl. 
Acad. Sci. USA 102, 4548–4553 (2005).
9. Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S. & Rubin, H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines 
on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). J. Biol. Chem. 281, 11456–63 (2006).
10. Warman, A. J. et al. Antitubercular pharmacodynamics of phenothiazines. J. Antimicrob. Chemother. 68, 869–880 (2013).
11. Dunn, E. A. et al. Incorporation of triphenylphosphonium functionality improves the inhibitory properties of phenothiazine 
derivatives in Mycobacterium tuberculosis. Bioorganic Med. Chem. 22, 5320–5328 (2014).
12. Iwata, M. et al. he structure of the yeast NADH dehydrogenase (Ndi1) reveals overlapping binding sites for water- and lipid-soluble 
substrates. Proc. Natl. Acad. Sci. USA 109, 15247–52 (2012).
13. Feng, Y. et al. Structural insight into the type-II mitochondrial NADH dehydrogenases. Nature 491, 478–82 (2012).
14. Heikal, A. et al. Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in 
energy generation. Mol. Microbiol. 91, 950–64 (2014).
15. Sena, F. V. et al. Type-II NADH:quinone oxidoreductase from Staphylococcus aureus has two distinct binding sites and is rate limited 
by quinone reduction. Mol. Microbiol. 98, 272–288 (2015).
16. Velázquez, I. & Pardo, J. P. Kinetic characterization of the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of 
mitochondria from Saccharomyces cerevisiae. Arch. Biochem. Biophys. 389, 7–14 (2001).
17. Eschemann, A., Galkin, A., Oettmeier, W., Brandt, U. & Kerscher, S. HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone), a high ainity 
inhibitor for mitochondrial alternative NADH dehydrogenase: evidence for a ping-pong mechanism. J. Biol. Chem. 280, 3138–3142 
(2005).
18. Yamashita, T., Nakamaru-Ogiso, E., Miyoshi, H., Matsuno-Yagi, A. & Yagi, T. Roles of bound quinone in the single subunit NADH-
quinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae. J. Biol. Chem. 282, 6012–6020 (2007).
19. Lin, S. S. et al. he Toxoplasma gondii type-II NADH dehydrogenase TgNDH2-I is inhibited by 1-hydroxy-2-alkyl-4(1H)quinolones. 
Biochim. Biophys. Acta 1777, 1455–1462 (2008).
20. Yano, T. et al. Mycobacterium tuberculosis type II NADH-menaquinone oxidoreductase catalyzes electron transfer through a two-site 
ping-pong mechanism and has two quinone-binding sites. Biochemistry 53, 1179–1190 (2014).
21. Yang, Y. et al. Reaction mechanism of single subunit NADH-ubiquinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae: 
evidence for a ternary complex mechanism. J. Biol. Chem. 286, 9287–97 (2011).
22. Salewski, J. et al. Substrate-protein interactions of Type II NADH:quinone oxidoreductase from Escherichia coli. Biochemistry 55, 
2722–2734 (2016).
23. Desplats, C. et al. Modification of substrate specificity in single point mutants of Agrobacterium tumefaciens type II NADH 
dehydrogenase. FEBS Lett. 581, 4017–4022 (2007).
24. Berkholz, D. S., Faber, H. R., Savvides, S. N. & Karplus, P. A. Catalytic cycle of human glutathione reductase near 1 Å resolution. J. 
Mol. Biol. 382, 371–384 (2008).
25. Lee, K. H., Humbarger, S., Bahnvadia, R., Sazinsky, M. H. & Crane, E. J. Characterization of the mechanism of the NADH-dependent 
polysulide reductase (Npsr) from Shewanella loihica PV-4: Formation of a productive NADH-enzyme complex and its role in the 
general mechanism of NADH and FAD-dependent enzymes. Biochim. Biophys. Acta 1844, 1708–1717 (2014).
26. Kussmaul, L. & Hirst, J. he mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine 
heart mitochondria. Proc. Natl. Acad. Sci. USA 103, 7607–12 (2006).
www.nature.com/scientificreports/
1 1SCIENTIFIC REPORTSȁ ?ǣ ? ? ? ? ?ȁǣ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?
27. Yakovlev, G. & Hirst, J. Transhydrogenation reactions catalyzed by mitochondrial NADH-ubiquinone oxidoreductase (complex I). 
Biochemistry 46, 14250–14258 (2007).
28. Cook, P. & Cleland, W. Enzyme Kinetics and Mechanism (Garland Science, 2007).
29. Mogi, T. et al. Identiication of new inhibitors for alternative NADH dehydrogenase (NDH-II). FEMS Microbiol. Lett. 291, 157–161 
(2009).
30. Shirude, P. S. et al. Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB agents. ACS Med. Chem. Lett. 3, 
736–740 (2012).
31. Pidathala, C. et al. Identiication, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II 
NADH:quinone oxidoreductase (PfNDH2). J. Med. Chem. 55, 1831–1843 (2012).
32. Deris, Z. Z. et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-
quinone oxidoreductase activity. J. Antibiot. 67, 147–151 (2014).
33. Amaral, L., Kristiansen, J. E., Viveiros, M. & Atouguia, J. Activity of phenothiazines against antibiotic-resistant Mycobacterium 
tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. J. 
Antimicrob. Chemother. 47, 505–511 (2001).
34. Liu, H. & Naismith, J. H. An eicient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis 
protocol. BMC Biotechnol. 8, 91 (2008).
35. Miroux, B. & Walker, J. E. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane 
proteins and globular proteins at high levels. J. Mol. Biol. 260, 289–298 (1996).
36. Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125–32 (2010).
37. Collaborative Computational Project, N. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. 
Crystallogr. 50, 760–3 (1994).
38. McCoy, A. J. et al. Phaser crystallographic sotware. J. Appl. Crystallogr. 40, 658–674 (2007).
39. Adams, P. D. et al. PHENIX: Building new sotware for automated crystallographic structure determination. Acta Crystallogr. Sect. 
D Biol. Crystallogr. 58, 1948–1954 (2002).
40. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 
486–501 (2010).
Acknowledgements
his work was funded by he Medical Research Council (grant number U105663141 to J.H.), the Maurice Wilkins 
Centre for Molecular Biodiscovery, and the Health Research Council of New Zealand. E.A.D. was supported by a 
University of Otago Doctoral Scholarship.
Author Contributions
J.N.B., H.R.B., D.A. and Y.N. designed and performed experiments and analyzed data with help from E.A.D. and 
A.H. J.N.B., Y.N. and J.H. wrote the manuscript with help from other authors; G.M.C., Y.N. and J.H. designed 
research and directed the project.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing inancial interests: he authors declare no competing inancial interests.
How to cite this article: Blaza, J. N. et al. he mechanism of catalysis by type-II NADH:quinone 
oxidoreductases. Sci. Rep. 7, 40165; doi: 10.1038/srep40165 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional ailiations.
his work is licensed under a Creative Commons Attribution 4.0 International License. he images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© he Author(s) 2017
